Medtech grants in the Netherlands

Open

Funds three €5M projects that build earlier, AI-assisted palliative care models for cancer patients and test them in real clinical and home-based settings.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds one €500K project that coordinates Europe's nuclear research network, connecting reactor science with medical and space uses of the field.

Open

Funds one €2M project to build EU production of medical isotopes like ytterbium-176, cutting reliance on Russian supply for cancer radiopharmaceuticals.

Open

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Open

Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.

Open

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Open

Funds existing ERC grant holders in testing the commercial or societal potential of already-funded research through a fixed EUR 150,000 top-up grant.

Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.

Awards EUR 20,000 to a woman scientist recognised for global-health research and mentorship in sub-Saharan Africa.

Awards EUR 50,000 to a research team recognised for South-North global-health partnerships on poverty-related diseases.

Awards EUR 15,000 to a male mid-career scientist based in the EU or an associated country for global-health leadership.

Awards EUR 15,000 to a woman mid-career scientist based in the EU or an associated country for global-health leadership.

Open

Funds international biotech R&D consortia through each country's own national funding scheme.

Open

Funds up to two projects that design AI-in-health training programmes jointly with universities, VET providers, hospitals and industry, delivered through Europe's AI screening-centre network.

Open

Funds hospital consortia to pilot cloud-based AI systems that read medical scans for cancer and cardiovascular screening, with clinicians validating every result.

Open

Funds one consortium EUR 24.4 million to run a programme that re-grants up to EUR 120,000 each to hospitals, public authorities and health-data holders across the EU.

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

Open

Funds early-career researchers building an independent research team and pursuing frontier research through an ERC Starting Grant hosted at a public or private research organisation.

Open

Funds teams that curate a valuable health dataset and prove its worth with a working AI application.

Open

Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.

Open

Funds research consortia developing biotechnology-based interventions, biomarkers or non-animal test methods that target the root causes of age-related disease.

Open

Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.